Magnum Ice Cream Sees Short Interest Jump to 19%, Shares Down 14%
Short interest in Magnum Ice Cream Co. has surged to 19% of available shares, more than double March’s level, making it the 18th most-shorted member of the Stoxx 600 as its stock falls 14% in 2026. Analysts cite rising GLP-1 drug usage and inflation pressures as key profit headwinds.
1. Surge in Short Interest
Data show short interest in Magnum Ice Cream Co. has risen to 19% of available shares, more than double its level a month ago, making it the 18th most-shorted stock in the Stoxx 600.
2. Share Price Performance
The stock has lost 14% in 2026, with shares dipping as much as 3.5% to €11.65, roughly 9% below its €12.80 debut price.
3. Headwinds from GLP-1 Drugs and Inflation
Analysts warn that increased usage of weight-loss GLP-1 drugs could curb demand for high-calorie desserts, while inflationary pressures linked to geopolitical risks have weighed on profit margins.
4. Hedge Fund Positioning
Regulatory filings show Walleye Capital raised its net short position by 24% to 3.8 million shares, with other funds like Marshall Wace and Ilex Capital Partners also boosting bearish bets.